| Appearance | Light Yellow Powder |
| Purity / Analysis Method | 99.5% (HPLC) (OAB) |
| Water Content (by KF) | NMT 1.0% w/w |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| Solubility | Slightly soluble in water |
Active Pharmaceutical Ingredients
Dolutegravir sodium
N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide Sodium Salt; Dolutegravir
Sodium Salt
| Purity / Analysis Method | 98.0% – 102.0% (HPLC) |
| Molecular Formula / Molecular Weight | C₂₀H₁₈F₂N₃NaO₅ = 441.37 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 1051375-19-9 |
| Unit | Price |
| 1 g | 7500 |
| 5 g | 9975 |
| 10 g | 17500 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
